drugset / Trial / NCT02366637
An Evaluation Of PF-03715455 In Moderate To Severe Chronic Obstructive Pulmonary Disease
RandomizedCrossoverTriple-blindTreatment
Summary
This study proposes to evaluate the safety and efficacy of PF-03715455 in subjects with moderate to severe Chronic Obstructive Pulmonary Disorder.
Timeline
- Start
- 2015-01
- Primary completion
- 2015-05
- Completion
- 2015-05
Outcome
Outcome not reported
Stopped (Business): “Study terminated on 7 April 2015 for business reasons. No safety and/or efficacy concerns contributed to the termination of the study”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-03715455 | Small molecule | 680 ug | Inhaled |